Howe & Rusling’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Howe & Rusling’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-355	Closed	-$4K	–	1105
2016 Q4	$4K	Hold	355	–	–	﹤0.01%	760
2016 Q3	$5K	Buy	+355	New	+$3.56K	﹤0.01%	696
2013 Q4	–	Sell	-196	Closed	-$4K	–	911
2013 Q3	$4K	Buy	+196	New	+$3.81K	﹤0.01%	744

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Howe & Rusling's ARIA Position: Q1 2017 in Review

Howe & Rusling sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 355 shares — an estimated $4K sold.

Howe & Rusling first reported a position in ARIA in Q3 2013 and held it in 3 quarters. The position peaked at $5K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Howe & Rusling reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Howe & Rusling sold 355 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $4K.
Howe & Rusling first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
Howe & Rusling's Ariad Pharmaceuticals Inc position peaked at $5K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Howe & Rusling's 13F filing for Q1 2017, filed 18 Apr 2017.